Chemed Corporation
Rating
Updated: Aug 28, 2026Key Statistics
Market Data
Valuation (TTM)
Valuation (NTM)
Cash Flow
Margins
Growth (CAGR)
Returns
Financial Health
Dividends
Profile
Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, doctors, registered nurses, home health aides, social workers, clergy, and volunteers prim...
Latest News
4 days ago · defenseworld.net
Waverly Advisors LLC Makes New $546,000 Investment in Chemed Corporation $CHEWaverly Advisors LLC acquired a new stake in Chemed Corporation (NYSE: CHE) in the undefined quarter, according to its most recent disclosure with the SEC. The fund acquired 1,173 shares of the company's stock, valued at approximately $546,000. A number of other institutional investors have also recently modified their holdings of CHE. Eukles
5 days ago · globenewswire.com
Roto-Rooter Buys Largest Franchisee TerritoryCINCINNATI, Sept. 16, 2026 (GLOBE NEWSWIRE) -- Roto-Rooter Services Company, a wholly owned subsidiary of Chemed Corporation ("Chemed") (NYSE: CHE) announced it has acquired the largest independent Roto-Rooter franchise, serving a population of approximately 11 million people, for $60.6 million.
6 days ago · seekingalpha.com
Chemed Corporation (CHE) Presents at 2026 Jefferies Healthcare Services and Technology Conference TranscriptChemed Corporation (CHE) Presents at 2026 Jefferies Healthcare Services and Technology Conference Transcript
13 days ago · globenewswire.com
Chemed Corporation to Present at the Jefferies 2026 Healthcare Services ConferenceCINCINNATI, Sept. 08, 2026 (GLOBE NEWSWIRE) -- Chemed Corporation (NYSE: CHE) today announced that it will deliver a presentation at the Jefferies 2026 Healthcare Services and Technology Conference on Tuesday, September 15, 2026, at approximately 10:55 a.m.
18 days ago · businesswire.com
CHEMED CORPORATION INVESTOR ALERT: Scott+Scott Attorneys at Law LLP Investigates Chemed Corporation's Directors and Officers for Breach of Fiduciary Duties – CHENEW YORK--(BUSINESS WIRE)---- $CHE #NYSE--Scott+Scott Attorneys at Law LLP has launched an urgent investigation into whether certain officers and directors of Chemed Corporation (NYSE: CHE) failed to manage Chemed in an acceptable manner, breaching their fiduciary duties to Chemed, and whether Chemed and its shareholders have suffered damages as a result. Attorney Joseph A. Pettigrew is heading the investigation—what shareholders need to know: On August 13, 2026, The Capital Forum released a report alleging t.
25 days ago · defenseworld.net
Bank of New York Mellon Corp Acquires Shares of 94,045 Chemed Corporation $CHEBank of New York Mellon Corp acquired a new position in shares of Chemed Corporation (NYSE: CHE) in the undefined quarter, according to its most recent Form 13F filing with the SEC. The firm acquired 94,045 shares of the company's stock, valued at approximately $43,800,000. Bank of New York Mellon Corp owned approximately
25 days ago · zacks.com
Chemed (CHE) Up 1.7% Since Last Earnings Report: Can It Continue?Chemed (CHE) reported earnings 30 days ago. What's next for the stock?
1 month ago · seekingalpha.com
Chemtrade Logistics Income Fund (CHE.UN:CA) Q2 2026 Earnings Call TranscriptChemtrade Logistics Income Fund (CHE.UN:CA) Q2 2026 Earnings Call Transcript
2 months ago · globenewswire.com
Chemed Corporation Declares Quarterly Dividend of 70 CentsCINCINNATI, Aug. 06, 2026 (GLOBE NEWSWIRE) -- Chemed Corporation (NYSE:CHE) announced today that the Board of Directors has declared a quarterly cash dividend of 70-cents per share on the Company's capital stock, payable on September 3, 2026, to shareholders of record as of August 17, 2026. This is a 10-cent, or 17%, increase over the 60-cent dividend paid in June 2026.
2 months ago · seekingalpha.com
Chemed Corporation: Why A Spin-Off Could Unlock Its Hidden ValueChemed Corporation (CHE) receives a Buy rating with a $632/share target, driven by activist pressure for a spin-off to eliminate the conglomerate discount. VITAS has successfully reengineered its patient mix, sharply reducing Medicare Cap penalties and driving 8.8% revenue growth and 18.2% Adjusted EBITDA margin in Q2. Roto-Rooter faces structural margin pressure from rising digital marketing costs, but B2B expansion and operational efficiencies are expected to support future growth.
Analyst Summary
Add to Watchlist
Select watchlists to add or remove CHE